Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Bausch + Lomb Corporation ( (BLCO) ) just unveiled an update.
Bausch + Lomb Corporation has announced it will release its fourth-quarter and full-year 2024 financial results on February 19, 2025, accompanied by a conference call and webcast to discuss these results and provide a business update. This release and the corresponding discussions are critical as they will shed light on the company’s financial health and strategic positioning in the eye health industry, potentially influencing stakeholder decisions and market perceptions.
More about Bausch + Lomb Corporation
Bausch + Lomb Corporation, founded in 1853, is a leading global company in the eye health industry, dedicated to enhancing vision for people worldwide. The company offers a comprehensive portfolio of around 400 products, including contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices. Bausch + Lomb operates in nearly 100 countries and has approximately 13,000 employees, with its headquarters in Vaughan, Ontario.
YTD Price Performance: -4.56%
Average Trading Volume: 473,078
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $6.05B
Find detailed analytics on BLCO stock on TipRanks’ Stock Analysis page.
